Natera (NTRA) Free Cash Flow Growth (1y) (2015 - 2026)
Natera (NTRA) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.62 Bn | 208.56 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 139.22 Bn | 134.87 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.07 Bn | 45.88 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.35 Bn | 37.54 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 38.18 Bn | 36.10 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 37.68 Bn | 36.58 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 28.60 Bn | 27.43 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.37 Bn | 28.32 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.30 Bn | 25.67 Bn | 1.03 Bn | 5.28% |
| 10 | Labcorp Holdings | 25.82 Bn | 24.84 Bn | 1.01 Bn | 165.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.33% |
| Dec 31, 2025 | 8.77% |
| Sep 30, 2025 | 4.25% |
| Jun 30, 2025 | 141.87% |
| Mar 31, 2025 | -15.81% |
| Dec 31, 2024 | 151.39% |
| Sep 30, 2024 | 191.77% |
| Jun 30, 2024 | 71.28% |
| Mar 31, 2024 | 132.51% |
| Dec 31, 2023 | 27.21% |
| Sep 30, 2023 | 71.59% |
| Jun 30, 2023 | 12.34% |
| Mar 31, 2023 | 40.65% |
| Dec 31, 2022 | 31.05% |
| Sep 30, 2022 | -49.00% |
| Jun 30, 2022 | -70.47% |
| Mar 31, 2022 | -63.71% |
| Dec 31, 2021 | -49.63% |
| Sep 30, 2021 | -253.80% |
| Jun 30, 2021 | -34.13% |